Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...
SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...
FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...
Pharmaceutical Technology on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
Chinese drugmaker Jiangsu Hengrui Pharmaceuticals has agreed to develop up to 12 of its drugs with British pharmaceutical giant GSK. Hengrui Pharma granted GSK an exclusive worldwide licence to its ...
Economist David C. Datelle says the pharmaceutical industry's prices have less to do with innovation than with corporate ...
USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is one of the best performing pharma stocks in 2025. Amylyx Pharmaceuticals, Inc. ...
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent ...
THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback